Factor analysis improves the selection of prescribing indicators

European Journal of Clinical Pharmacology

Volumn 62, Issue 11, 2006, Pages 953-958

  Skyggedal Rasmussen, Hanne Marie ^a,c   Søndergaard, Jens ^b   Sokolowski, Ineta ^b   Kampmann, Jens Peter ^c   Andersen, Morten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c DANISH MEDICINES AGENCY   (Denmark)

Author keywords

Anti inflammatory agents; Factor analysis; General practice; Non steroidal; Prescribing indicators; Quality of prescribing

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIULCER AGENT; CELECOXIB; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PROTON PUMP INHIBITOR; ROFECOXIB; TRAMADOL;

ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG COST; DRUG FORMULARY; FACTORIAL ANALYSIS; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DATABASES, FACTUAL; DENMARK; EVIDENCE-BASED MEDICINE; FACTOR ANALYSIS, STATISTICAL; FAMILY PRACTICE; HUMANS; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 33750431026     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0196-x     Document Type: Article

References (31)

1. Campbell SM, Roland MO, Quayle JA, Buetow SA, Shekelle PG (1998) Quality indicators for general practice: which ones can general practitioners and health authority managers agree are important and how useful are they? J Public Health Med 20:414-421
2. Ashworth M, Golding S, Majeed A (2002) Prescribing indicators and their use by primary care groups to influence prescribing. J Clin Pharm Ther 27:197-204
3. Avery AJ, Heron T, Lloyd D, Harris CM, Roberts D (1998) Investigating relationships between a range of potential indicators of general practice prescribing: an observational study. J Clin Pharm Ther 23:441-450
4. Schubert I, Ihle P, Koster I, von Ferber L (1999) Markers to analyse the prescribing of non-steroidal anti-inflammatory drugs in ambulatory care. A guide to pursuing rational and safe prescribing. Eur J Clin Pharmacol 55:479-486
5. Shelley M, Croft P, Chapman S, Pantin C (2000) Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? J Clin Epidemiol 53:1217-1221
6. Williams D, Kelly A, Feely J (2000) Drug interactions avoided - a useful indicator of good prescribing practice. Br J Clin Pharmacol 49:369-372
7. Majeed A, Evans N, Head P (1997) What can PACT tell us about prescribing in general practice? BMJ 315:1515-1519
8. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H et al (1998) Drug utilization 90% - a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 54:113-118
9. Marshall M, Campbell S, Hacker J, Roland M. (eds.) Quality indicators for general practice. A practical guide for health professionals and managers. The Royal Society of Medicine Press, Manchester 2002:1-14
10. Barber N (1995) What constitutes good prescribing? BMJ 310:923-925
11. Skyggebal Rasmussen H, Sondergaard J, Kampmann JP, Andersen M (2005) General practitioners prefer prescribing indicators based on detailed information on individual patients: a Delphi study. Eur J Clin Pharmacol 61(3):237-241
12. Glintborg D, Unkerskov J, Bach KF, Rasmussen H, Kampmann JP (2002) NSAID - ømme punkter (NSAID - controversies) (In Danish). Rationel Farmakoterapi 8:1-4
13. Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445-448
14. Pedersen KM (2003) Pricing and reimbursement of drugs in Denmark. Eur J Health Econom 4:60-65
15. Kim J-O, Mueller CW (1978) Factor Analysis, Statistical Methods and Practical Issues, eds Uslaner EM. Iowa: Sage Universal Paper series on Factor Analyses 5-59
16. Somerset M, Peters TJ, Sharp DJ, Campbell R (2003) Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Qual Life Res 12:21-29
17. Mardia KV, Kent JT, Bibby JM (1979) Multivariate Analysis. London: Academic Press
18. Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM (2001) Comparison of indicators assessing the quality of drug prescribing for asthma. Health Serv Res 36:143-161
19. Mainous AG 3rd (1993) Factor analysis as a tool in primary care research. Fam Pract 10:330-339
20. Wright B, Scott I, Woloschuk W, Brenneis F (2004) Career choice of new medical students at three Canadian universities: family medicine versus specialty medicine. CMAJ 170:1920-1924
21. Ekedahl A, Månsson N (2004) Unclaimed prescriptions after automated prescription transmissions to pharmacies. Pharm World Sci 26:26-31
22. Bergman U, Andersen M, Vaccheri A, Bjerrum L, Wettermark B, Montanaro N (2000) Deviations from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European regions. Eur J Clin Pharmacol 56:269-272
23. Graham DJ, Campen D, Hui R, Spence M, Cheetham C et al (2005) Risk of acute myocardial infartion and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested casecontrol study. Lancet 365:475-481
24. Bird SM, Cox D, Farewell VT, Goldstein H, Holt T, Smith PC (2003) Royal Statistical Society Working Party on Performance Monitoring in the Public Services. Performance Indicators: Good, Bad, and Ugly. Available at: http://www.rss.org.uk/PDF/PerformanceMonitoring.pdf. accessed October 2004
25. Muijrers PEM, Janknegt R, Sijbrandij J, Grol RPTM, Knottnerus JA (2004) Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners. Eur J Clin Pharm 60:739-746
26. Coste J, Sene B, Milstein C, Bouee S, Venot A (1998) Indicators for the automated analysis of drug prescribing quality. Methods Inf Med 37:38-44
27. Knight EL, Avorn J (2001) Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 35:703-710
28. Pont LG, Denig P, van der MT, van der Veen WJ, Haaijer-Ruskamp FM (2004) Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol 59:833-840
29. Hoven JL, Haaijer-Ruskamp FM, Vander Stichele RH (2005) Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). Eur J CIin Pharmacol 60:831-834
30. Bateman DN, Eccles M, Campbell M, Soutter J, Roberts SJ, Smith JM (1996) Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract 46:20-25
31. Morris C, Cantrill J (2002) Preventable drug-related morbidity indicators in the U.S. and U.K. J Manag Care Pharm 8:372-377